Apr 03, 2017 11:30 am UTC| Business
BASKING RIDGE, N.J., April 03, 2017 -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius” or the “Company”), a cell therapy company advancing a select therapeutic development pipeline,announces today that four...
ChinaNet Online Holdings Reports Fiscal Year 2016 Financial Results
Apr 03, 2017 11:30 am UTC| Business
Revenues of $34.8 million in 2016, up 7.7% from prior year's $32.3 millionSearch engine marketing service revenue increased 59.0% to $17.6 million for the yearGross profit of $7.8 million generated in 2016, a 1.9% increase...
Amicus Therapeutics Completes Enrollment in ESSENCE Phase 3 Epidermolysis Bullosa Clinical Study
Apr 03, 2017 11:30 am UTC| Business
Target Exceeded with More than 160 Patients Enrolled Top-Line Data on Track for 3Q17 CRANBURY, N.J., April 03, 2017 -- Amicus Therapeutics (Nasdaq:FOLD), a global biotechnology company at the forefront of therapies...
Apr 03, 2017 11:30 am UTC| Business
- MGL-3196, a liver-directed thyroid hormone receptor (THR) beta selective agonist, has the potential to treat NASH (non-alcoholic steatohepatitis) and familial hypercholesterolemia (FH) - - Madrigal is well positioned...
Electric Boats and Ships Markets, 2027
Apr 03, 2017 11:28 am UTC| Business
Dublin, April 03, 2017 -- Research and Markets has announced the addition of the "Electric Boats and Ships 2017-2027" report to their offering. This brand-new report looks at this...
Apr 03, 2017 11:21 am UTC| Business
Dublin, April 03, 2017 -- Research and Markets has announced the addition of the "Supercapacitor Technologies and Markets 2016-2026" report to their offering. The high-power energy...
BioCryst Announces Mundipharma Receives Approval for Mundesine® in Japan
Apr 03, 2017 11:18 am UTC| Business
RESEARCH TRIANGLE PARK, N.C., April 03, 2017 -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) announced today that Mundipharma has obtained regulatory approval of Mundesine® (Forodesine hydrochloride) for the treatment...
US–India Trade Talks Race Toward USD 500 Billion Goal